Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RPRX

Royalty Pharma plc

Mar 06 • 04:00PM ET

33.28

Dollar change -0.49
Percentage change -1.45	%

Healthcare • Biotechnology • USA • NASD

Peers: BIIB REGN VRTX GILD INCY ALNY EXEL NBIX MDGL DKNG

| Held by: VTI VO VXF VTV VOE VYM IWR VHT DGRO SCHM

Scroll to Statements

Index	-	P/E	17.36	EPS (ttm)	1.92	Insider Own	22.29%	Shs Outstand	445.99M	Perf Week	-0.27%
Market Cap	19.19B	Forward P/E	6.35	EPS next Y	5.24	Insider Trans	0.00%	Shs Float	336.74M	Perf Month	6.46%
Income	858.77M	PEG	1.35	EPS next Q	1.07	Inst Own	74.42%	Short Float	4.54%	Perf Quarter	25.92%
Sales	2.26B	P/S	8.47	EPS this Y	13.78%	Inst Trans	1.15%	Short Ratio	3.68	Perf Half Y	15.24%
Book/sh	15.58	P/B	2.14	EPS next Y	11.54%	ROA	4.96%	Short Interest	15.30M	Perf Year	11.34%
Cash/sh	1.71	P/C	19.43	EPS next 5Y	12.82%	ROE	12.75%	52W Range	24.05 - 34.20	Perf YTD	30.46%
Dividend Est.	0.93 (2.80%)	P/FCF	6.87	EPS past 5Y	-21.51%	ROI	6.33%	52W High	-2.69%	Beta	0.46
Dividend TTM	0.85 (2.55%)	Quick Ratio	1.44	Sales past 5Y	4.79%	Gross Margin	-	52W Low	38.38%	ATR (14)	0.68
Dividend Ex-Date	Feb 21, 2025	Current Ratio	1.44	EPS Y/Y TTM	-24.34%	Oper. Margin	57.07%	RSI (14)	61.08	Volatility	1.77% 2.12%
Employees	99	Debt/Eq	1.10	Sales Y/Y TTM	-3.85%	Profit Margin	37.93%	Recom	1.44	Target Price	41.00
Option/Short	Yes / Yes	LT Debt/Eq	0.95	EPS Q/Q	-57.76%	Payout	43.94%	Rel Volume	0.57	Prev Close	33.77
Sales Surprise	7.99%	EPS Surprise	9.15%	Sales Q/Q	-0.34%	Earnings	Feb 11 BMO	Avg Volume	4.16M	Price	33.28
SMA20	1.07%	SMA50	9.32%	SMA200	18.94%	Trades		Volume	2,370,752	Change	-1.45%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-24	Downgrade	UBS	Buy → Neutral	$28
Jun-14-22	Resumed	UBS	Buy	$47
May-13-22	Initiated	Scotiabank	Sector Outperform	$53
Apr-27-22	Initiated	Goldman	Buy	$56
Apr-14-22	Upgrade	JP Morgan	Neutral → Overweight	$50
Apr-06-22	Resumed	Morgan Stanley	Overweight	$48
Oct-29-21	Upgrade	Citigroup	Neutral → Buy	$50
Jul-30-21	Initiated	Tigress Financial	Buy	$50
Nov-09-20	Upgrade	UBS	Neutral → Buy	$52 → $51
Jul-14-20	Initiated	Evercore ISI	In-line
Jul-13-20	Initiated	UBS	Neutral	$52
Jul-13-20	Initiated	SunTrust	Buy	$56
Jul-13-20	Initiated	Morgan Stanley	Equal-Weight	$51
Jul-13-20	Initiated	JP Morgan	Neutral	$50
Jul-13-20	Initiated	Goldman	Neutral	$47
Jul-13-20	Initiated	Cowen	Outperform	$55
Jul-13-20	Initiated	Citigroup	Neutral	$50
Jul-13-20	Initiated	BofA Securities	Buy	$55

Show Previous Ratings

Feb-27-25 04:15PM	Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference (GlobeNewswire)
Feb-23-25 03:03PM	Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025 (Insider Monkey)
Feb-13-25 07:57PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
Feb-12-25 09:06AM	Analyst Report: Royalty Pharma plc (Morningstar Research)
06:30AM	Royalty Pharma Announces R&D Funding Collaboration With Biogen (GlobeNewswire)
02:07AM	Loading…
02:07AM	Royalty Pharma PLC (RPRX) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ... (GuruFocus.com)
Feb-11-25 07:33AM	Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue Estimates (StockStory)
07:15AM	Royalty Pharma Reports Q4 and Full Year 2024 Results (GlobeNewswire)
Feb-10-25 08:03AM	Royalty Pharma Earnings: What To Look For From RPRX (StockStory)
Jan-29-25 09:00AM	Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds (GlobeNewswire)
Jan-28-25 04:15PM	Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025 (GlobeNewswire)
Jan-23-25 06:29AM	Why Is Andreas Halvorsen Bullish On Royalty Pharma plc (RPRX) Now? (Insider Monkey)
Jan-15-25 01:52PM	Royalty Pharma plc (RPRX): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey)
Jan-12-25 11:24AM	Heres Why Royalty Pharma plc (RPRX) Led This Weeks Rally (Insider Monkey)
Jan-11-25 01:10PM	Did Royalty Pharma (RPRX) Close Shortened Trading Week Higher? (Insider Monkey)
07:30AM	Loading…
Jan-10-25 07:30AM	Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +12.56%
07:15AM	Royalty Pharma Announces Transformative Step in Company's Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program (GlobeNewswire)
Jan-09-25 04:15PM	Royalty Pharma Announces Dividend Increase (GlobeNewswire)
Dec-27-24 05:47AM	Jim Cramer on Royalty Pharma plc (RPRX): Disappointing Stock, Man, I Cant Believe It (Insider Monkey)
Dec-24-24 04:45AM	Jim Cramer Calls Royalty Pharma (RPRX) Disappointing But Recommends Holding I Want You To Stick With It (Insider Monkey)
Dec-19-24 08:06PM	Lightning Round: MandT Bank is a buy, I like the banks, says Jim Cramer (CNBC TV)
Nov-27-24 04:15PM	Royalty Pharma to Present at Upcoming Investor Conferences (GlobeNewswire)
11:11AM	Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood? (Insider Monkey)
Nov-14-24 04:30PM	Royalty Pharma Announces Inaugural Prize for Impact in Healthcare (GlobeNewswire)
Nov-07-24 07:10AM	Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million (GlobeNewswire)
02:10AM	Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions (GuruFocus.com)
12:08AM	Royalty Pharma PLC (RPRX): A Strategic SWOT Insight (GuruFocus.com)
Nov-06-24 07:16PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
07:15AM	Royalty Pharma Reports Third Quarter 2024 Results (GlobeNewswire)
Nov-04-24 04:15PM	Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo (GlobeNewswire)
04:01PM	Loading…
04:01PM	Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo (PR Newswire)
Nov-03-24 06:11AM	Morgan Stanley Predicts Up to 670% Jump for These 2 Strong Buy Stocks (TipRanks)
Oct-16-24 04:15PM	Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024 (GlobeNewswire)
Oct-11-24 08:15AM	Royalty Pharma Declares Fourth Quarter 2024 Dividend (GlobeNewswire)
Oct-09-24 05:31PM	Royalty Pharma PLC (RPRX) Q2 2024 Earnings Call Highlights: Surpassing Growth Expectations and ... (GuruFocus.com)
03:50PM	Royalty Pharma plc (RPRX): Among The Stocks With Biggest Upside Potential According to Hedge Funds (Insider Monkey)
Sep-03-24 05:14PM	Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement (GlobeNewswire)
05:06PM	Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement (GlobeNewswire)
Aug-28-24 04:15PM	Royalty Pharma to Present at Morgan Stanley's 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-26-24 06:16AM	Jim Cramer on Royalty Pharma plc (NASDAQ:RPRX): Its Been a Bit of a Bust, I Feel Badly (Insider Monkey)
Aug-23-24 05:32AM	Jim Cramer's Latest Lightning Round: Top 10 Stocks (Insider Monkey)
Aug-17-24 03:58PM	Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now? (Insider Monkey)
Aug-16-24 06:09PM	10 Best Defensive Stocks To Buy Now (Insider Monkey)
Aug-09-24 01:05AM	Royalty Pharma PLC (RPRX): A Strategic SWOT Insight (GuruFocus.com)
Aug-08-24 04:16PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
07:00AM	Royalty Pharma Reports Second Quarter 2024 Results (GlobeNewswire)
Jul-24-24 08:30AM	Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital (GlobeNewswire)
Jul-19-24 08:15AM	Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
Jul-17-24 04:15PM	Royalty Pharma Declares Third Quarter 2024 Dividend (GlobeNewswire)
Jul-15-24 12:10PM	Will Royalty Pharma (RPRX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-02-24 07:44PM	Is Royalty Pharma plc (RPRX) a Good Stock to Buy Now? (Insider Monkey)
06:58PM	10 Best Undervalued Stocks To Buy Now (Insider Monkey)
Jun-26-24 06:00AM	Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024 (InvestorPlace)
Jun-24-24 12:56PM	7 Biotech Stocks to Buy on the Dip: June 2024 (InvestorPlace)
Jun-05-24 06:14AM	June's Biotech Boom: 3 Stocks to Buy for a Summertime Surge (InvestorPlace)
Jun-04-24 04:15PM	Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
Jun-03-24 05:15PM	Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes (GlobeNewswire)
May-28-24 07:10AM	Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million (GlobeNewswire)
May-27-24 06:28PM	Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now? (Insider Monkey)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
May-22-24 04:10PM	Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline (GlobeNewswire)
04:00PM	Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline (GlobeNewswire)
May-20-24 02:41PM	7 Dividend Stocks to Buy at a 52-Week Low (InvestorPlace)
May-13-24 08:15AM	Royalty Pharma to Present at Upcoming Investor Conferences (GlobeNewswire)
May-10-24 01:07AM	Royalty Pharma PLC (RPRX): A Strategic SWOT Insight (GuruFocus.com)
May-09-24 03:35PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
12:00PM	Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
11:56AM	RPRX Stock Earnings: Royalty Pharma Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
10:46AM	Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:10AM	Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates (Zacks)
07:00AM	Royalty Pharma Reports First Quarter 2024 Results (GlobeNewswire)
06:45AM	Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab (GlobeNewswire)
May-08-24 08:51AM	Why Earnings Season Could Be Great for Royalty Pharma (RPRX) (Zacks)
May-06-24 09:16AM	Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics (Zacks)
May-02-24 04:01PM	Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma (Business Wire)
10:01AM	Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-30-24 08:37AM	PureTech Health plc (NASDAQ:PRTC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-19-24 08:15AM	Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 (GlobeNewswire)
Apr-17-24 08:15AM	Royalty Pharma Declares Second Quarter 2024 Dividend (GlobeNewswire)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Feb-28-24 04:15PM	Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference (GlobeNewswire)
Feb-20-24 12:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Feb-17-24 12:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Feb-16-24 03:30PM	Royalty Pharma (RPRX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:45AM	Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:04AM	Royalty Pharma PLC (RPRX): A Strategic SWOT Insight (GuruFocus.com)
Feb-15-24 11:08PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
07:58AM	Royalty Pharma PLC (RPRX) Earnings Report: A Detailed Analysis (GuruFocus.com)
07:30AM	Royalty Pharma Reports Q4 and Full Year 2023 Results (GlobeNewswire)
Jan-31-24 01:04AM	What Makes Royalty Pharma plc (RPRX) a Compelling Stock? (Insider Monkey)
Jan-30-24 04:15PM	Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024 (GlobeNewswire)
Jan-19-24 08:15AM	Royalty Pharma Announces Dividend Increase (GlobeNewswire)
Jan-08-24 07:00AM	Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 05:30AM	Should You Sell Royalty Pharma plc (RPRX)? (Insider Monkey)
Nov-27-23 04:15PM	Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference (GlobeNewswire)
Nov-13-23 08:10AM	Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program (GlobeNewswire)
08:00AM	Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program (Business Wire)
Nov-09-23 04:33PM	Royalty Pharma plc (NASDAQ:RPRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:15AM	The Royalty Pharma PLC (RPRX) Company: A Short SWOT Analysis (GuruFocus.com)
Nov-08-23 07:00AM	Royalty Pharma Reports Third Quarter 2023 Results (GlobeNewswire)

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RPRX

Royalty Pharma plc

Upgrade your FINVIZ experience